Should We Still Feel Reluctant About Prescribing Rivaroxaban for Advanced Chronic Kidney Disease?

JACC Adv. 2024 Jan 4;3(2):100812. doi: 10.1016/j.jacadv.2023.100812. eCollection 2024 Feb.

Authors

George Ntaios¹, Dimitrios Sagris¹, Anastasia Adamou¹

Affiliation

¹ Faculty of Medicine, Department of Internal Medicine, School of Health Sciences, University of Thessaly, Larissa, Thessaly, Greece.

No abstract available

Keywords: atrial fibrillation; direct oral anticoagulants; renal disease; vitamin K agonists.

Publication types

Editorial